US Funds Controversial Hepatitis B Vaccine Study in Africa
TL;DR Summary
The Trump administration awarded a controversial $1.6 million no-bid contract to a Danish university to study hepatitis B vaccinations in Guinea-Bissau, raising ethical concerns due to the withholding of vaccines from some newborns in a randomized trial, which critics argue is unethical and could exacerbate vaccine hesitancy.
- US awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies AP News
- US plan for $1.6m hepatitis B vaccine study in Africa called ‘highly unethical’ The Guardian
- CDC to Fund Controversial Study in West Africa on Infant Hepatitis B Vaccines NOTUS — News of the United States
- CDC awards grant to controversial Danish researchers with ties to top FDA official statnews.com
- CDC Gives Danish Researchers $1.6M to Study Hep B Vaccine Birth Dose in Africa MedPage Today
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
4 min
vs 5 min read
Condensed
95%
934 → 47 words
Want the full story? Read the original article
Read on AP News